scispace - formally typeset
M

Muzaffer Bilgin

Researcher at Eskişehir Osmangazi University

Publications -  70
Citations -  436

Muzaffer Bilgin is an academic researcher from Eskişehir Osmangazi University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 60 publications receiving 291 citations.

Papers
More filters
Journal ArticleDOI

Effects of Sleep Disorders on Hemoglobin A1c Levels in Type 2 Diabetic Patients.

TL;DR: Sleep disorders are common in diabetic patients and negatively affect the control of diabetes, and poor diabetes control is an important factor disturbing sleep quality.
Journal ArticleDOI

Scalp Dermatoscopic Findings in Androgenetic Alopecia and Their Relations with Disease Severity

TL;DR: In the characteristic trichoscopic findings in this study, perifollicular pigmentation was found as a normal feature of the scalp, whereas multihair follicular unit and honeycomb pigment pattern, which were previously considered as normal features, were observed to be related to androgenetic alopecia.
Journal ArticleDOI

Dermoscopic findings in scalp psoriasis and seborrheic dermatitis; two new signs; signet ring vessel and hidden hair.

TL;DR: This study confirmed that trichoscopy might be useful in differentiating scalp psoriasis and seborrheic dermatitis from each other and from other noncicatricial alopecia with three trichoscopic structures as HH, SRV and CV.
Journal ArticleDOI

Trichoscopic findings in alopecia areata and their relation to disease activity, severity and clinical subtype in Turkish patients.

TL;DR: The objective was to determine the relationship of trichoscopic findings in alopecia areata with disease activity, severity and clinical subtype in Turkish patients.
Journal ArticleDOI

Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors

TL;DR: To evaluate the long‐term oncological and reproductive outcomes of patients aged 25 years and younger who were treated by fertility‐sparing cytoreductive surgery plus adjuvant chemotherapy (ACT) or observation alone for malignant ovarian germ cell tumors (MOGCT).